Fact CheckerSign in

NCT07216040Not yet recruiting

Harnessing Optimism and Perseverance in the Face of Long COVID-Español

Harnessing Optimism and Perseverance in the Face of Long COVID~Español (HOPE-LC~Español)

Source: ClinicalTrials.gov · Last updated 23 Apr 2026

Brief summary (registry, in English)

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC\~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
25 (estimated)
First submitted
9 Oct 2025
Start date
May 2026
Primary completion date
31 Aug 2026
Lead sponsor
Icahn School of Medicine at Mount Sinai
NCT number
NCT07216040

What you commit to

  • Study type: Interventional
  • Planned participants: 25
  • From May 2026 to the primary completion date, 31 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms.

Other illness

  • Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention).

Other

  • Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions.
  • Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations.

Who the study is looking for

  • Age 18 years or older.
  • Speaks and understands Spanish at a level that allows active participation in group-based study procedures.
  • Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms.
  • Ability to participate in group sessions either in-person or via telehealth (Zoom).
  • Willingness and capacity to provide informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brain Injury Research Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.